Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 05, 2022 |
referred to health |
May 25, 2021 |
referred to health |
Assembly Bill A7829
2021-2022 Legislative Session
Sponsored By
DINOWITZ
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
2021-A7829 (ACTIVE) - Details
2021-A7829 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7829 2021-2022 Regular Sessions I N A S S E M B L Y May 25, 2021 ___________ Introduced by M. of A. DINOWITZ -- read once and referred to the Commit- tee on Health AN ACT to amend the public health law, in relation to requiring the immunization of certain post-secondary students against COVID-19 THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 13 of section 2165 of the public health law is renumbered subdivision 12 and subdivision 1, as added by chapter 405 of the laws of 1989, paragraph b as amended by chapter 325 of the laws of 1991, is amended to read as follows: 1. As used in this section, unless the context requires otherwise: a. The term "institution" means a college as defined in section two of the education law. b. The term "student" means any person born on or after January first, nineteen hundred fifty-seven, who is registered to attend or attends classes at an institution, whether full-time or part-time. "Part-time student" shall mean a student who is enrolled for at least six but less than twelve semester hours, or the equivalent per semester or at least four but less than eight semester hours per quarter at an institution. c. The term "health practitioner" means any person authorized by law to administer an immunization. d. The term "immunization" means an adequate dose or doses of an immunizing agent against measles, mumps [and], rubella AND THE NOVEL CORONAVIRUS (COVID-19) which meets the standards approved by the United States public health service for such biological products, and which is approved by the state department of health under such conditions as may be specified by the public health council. § 2. This act shall take effect thirty days following the date of the issuance of a biologics license for an immunizing agent against COVID-19 by the United States Food and Drug Administration provided that the provisions contained in this act are in accordance with recommendations EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.